BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 30867826)

  • 1. Immune targets in the tumor microenvironment treated by radiotherapy.
    Ozpiskin OM; Zhang L; Li JJ
    Theranostics; 2019; 9(5):1215-1231. PubMed ID: 30867826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irradiation and immunotherapy: From concept to the clinic.
    Salama AK; Postow MA; Salama JK
    Cancer; 2016 Jun; 122(11):1659-71. PubMed ID: 26914620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
    Darragh LB; Oweida AJ; Karam SD
    Front Immunol; 2018; 9():3154. PubMed ID: 30766539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types.
    van den Ende T; van den Boorn HG; Hoonhout NM; van Etten-Jamaludin FS; Meijer SL; Derks S; de Gruijl TD; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188386. PubMed ID: 32540465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review.
    Dar TB; Biteghe FAN; Kakar-Bhanot R; Aniogo EC; Malindi Z; Akinrinmade OA; Chalomie NET; Kombe Kombe AJ; Aboughe Angone S; Ndong JMN; Ndong JD
    Clin Transl Oncol; 2022 Dec; 24(12):2255-2271. PubMed ID: 35913663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy and immunotherapy: a beneficial liaison?
    Weichselbaum RR; Liang H; Deng L; Fu YX
    Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologically augmented cancer treatment using modern radiotherapy.
    Durante M; Reppingen N; Held KD
    Trends Mol Med; 2013 Sep; 19(9):565-82. PubMed ID: 23831337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.
    Derer A; Frey B; Fietkau R; Gaipl US
    Cancer Immunol Immunother; 2016 Jul; 65(7):779-86. PubMed ID: 26590829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
    Shahabi V; Postow MA; Tuck D; Wolchok JD
    Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy.
    Andersson P; Ostheimer C
    Front Immunol; 2019; 10():2083. PubMed ID: 31555290
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune Priming of the Tumor Microenvironment by Radiation.
    Jiang W; Chan CK; Weissman IL; Kim BYS; Hahn SM
    Trends Cancer; 2016 Nov; 2(11):638-645. PubMed ID: 28741502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.
    Philips GK; Atkins M
    Int Immunol; 2015 Jan; 27(1):39-46. PubMed ID: 25323844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
    Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
    Front Immunol; 2019; 10():407. PubMed ID: 30930892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
    Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
    Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment.
    Ishihara D; Pop L; Takeshima T; Iyengar P; Hannan R
    Cancer Immunol Immunother; 2017 Mar; 66(3):281-298. PubMed ID: 27743027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer.
    Dudzinski SO; Cameron BD; Wang J; Rathmell JC; Giorgio TD; Kirschner AN
    J Immunother Cancer; 2019 Aug; 7(1):218. PubMed ID: 31412954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Dynamics in Tumor Microenvironment Under Radiotherapy.
    Huang J; Li JJ
    Adv Exp Med Biol; 2020; 1263():175-202. PubMed ID: 32588328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma.
    Martinez-Zubiaurre I; Chalmers AJ; Hellevik T
    Front Immunol; 2018; 9():1679. PubMed ID: 30105016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.
    Mushtaq MU; Papadas A; Pagenkopf A; Flietner E; Morrow Z; Chaudhary SG; Asimakopoulos F
    J Immunother Cancer; 2018 Jul; 6(1):65. PubMed ID: 29970158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership.
    Chajon E; Castelli J; Marsiglia H; De Crevoisier R
    Crit Rev Oncol Hematol; 2017 Mar; 111():124-132. PubMed ID: 28259287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.